Skip to main navigation Skip to search Skip to main content

Parallel Genetic and Immune Studies in conjunction with ARGX-113-1904 (Efgartigimod)

Project: Research

Project Details

StatusFinished
Effective start/end date01/14/2101/31/26

Funding

  • argenx BVBA: $1,685,131.00